ArticlePloS one2021

A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats.

Pierre E Signore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.